| Product Code: ETC13220014 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Contraceptive Drugs and Devices Market was valued at USD 28 Billion in 2024 and is expected to reach USD 42 Billion by 2031, growing at a compound annual growth rate of 4.40% during the forecast period (2025-2031).
The Global Contraceptive Drugs and Devices Market is experiencing steady growth due to increasing awareness about family planning and the availability of a wide range of contraceptive options. The market is driven by factors such as the rising prevalence of unintended pregnancies, growing initiatives by governments and NGOs to promote contraception, and advancements in contraceptive technology. Oral contraceptives, intrauterine devices (IUDs), condoms, and contraceptive implants are among the key product segments contributing to market growth. Additionally, the increasing adoption of long-acting reversible contraceptives (LARCs) and the development of innovative drug delivery systems further propel market expansion. Geographically, North America and Europe hold significant market shares, while emerging economies in Asia-Pacific and Latin America present lucrative opportunities for market players to expand their presence and offerings.
The Global Contraceptive Drugs and Devices Market is experiencing a significant shift towards long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and hormonal implants. This trend is driven by the increasing awareness about the effectiveness and convenience of LARCs compared to other contraceptive methods. Additionally, the market is witnessing a growing demand for non-hormonal contraceptive options due to concerns about side effects associated with hormonal contraceptives. Emerging markets in Asia-Pacific and Latin America present lucrative opportunities for market players to expand their presence and tap into the growing demand for contraceptives. Technological advancements in contraceptive devices, such as the development of smartphone-connected contraceptive implants, also offer innovative opportunities for growth in the market. Overall, the Global Contraceptive Drugs and Devices Market is poised for continued growth and innovation in the coming years.
The Global Contraceptive Drugs and Devices Market faces several challenges, including regulatory hurdles, cultural barriers, and access issues. Regulatory requirements for approval of new contraceptive drugs and devices vary across regions, leading to delays in product launches and market penetration. Cultural factors and societal norms in certain regions may limit the acceptance and adoption of contraceptive methods, posing a barrier to market growth. Additionally, limited access to healthcare services, particularly in rural or underserved areas, hinders the availability and distribution of contraceptive products to those in need. Addressing these challenges requires collaboration between industry stakeholders, policymakers, healthcare providers, and advocacy groups to improve regulatory frameworks, increase awareness, and enhance access to effective contraceptive options globally.
The Global Contraceptive Drugs and Devices Market is primarily driven by factors such as increasing awareness about family planning, rising prevalence of sexually transmitted infections, advancements in contraceptive technologies, and government initiatives to promote population control. Additionally, changing lifestyle patterns, growing female workforce participation, and the availability of a wide range of contraceptive options are fueling market growth. The shift towards long-acting reversible contraceptives (LARCs) and the development of innovative drug delivery systems are also key drivers in the market. Furthermore, the increasing focus on male contraception methods and the expanding healthcare infrastructure in emerging economies are expected to contribute to the market expansion in the coming years.
Government policies related to the Global Contraceptive Drugs and Devices Market vary by country. Many governments support initiatives to increase access to contraceptives through public health programs, subsidies, and education campaigns to promote family planning and reduce unwanted pregnancies. Some governments also regulate the manufacturing, distribution, and marketing of contraceptive drugs and devices to ensure safety, efficacy, and quality standards are met. Additionally, certain countries may have policies in place to provide free or subsidized contraceptives to low-income populations to address disparities in access to family planning services. Overall, government policies play a significant role in shaping the market dynamics of contraceptive drugs and devices globally by influencing availability, affordability, and awareness of these products.
The Global Contraceptive Drugs and Devices Market is expected to witness significant growth in the coming years due to increasing awareness about family planning, rising prevalence of sexually transmitted diseases, and the growing trend of dual income households. The market is likely to be driven by the introduction of innovative contraceptive products, advancements in technology such as long-acting reversible contraceptives (LARCs), and the expanding availability of over-the-counter contraceptives. Additionally, the increasing focus on women`s health and empowerment, along with government initiatives to promote family planning, are anticipated to further boost market growth. However, challenges such as social stigmas associated with contraception, regulatory hurdles, and limited access to healthcare in developing regions may hinder the market`s expansion to some extent. Overall, the Global Contraceptive Drugs and Devices Market is poised for steady growth in the foreseeable future.
The global contraceptive drugs and devices market is experiencing diverse trends across different regions. In Asia, the market is driven by the rising awareness about family planning and increasing government initiatives to promote contraceptives. North America is witnessing a shift towards long-acting reversible contraceptives (LARCs) due to their high efficacy rates. In Europe, there is a growing demand for non-hormonal contraceptive options and increased focus on personalized contraceptive solutions. The Middle East and Africa region is seeing a gradual acceptance of modern contraceptive methods, although cultural and social barriers still exist. Latin America is experiencing growth in demand for emergency contraceptives and a rise in investments in sexual and reproductive health programs. Overall, the global contraceptive drugs and devices market is dynamic, with each region showcasing unique opportunities and challenges.
Global Contraceptive Drugs and Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Contraceptive Drugs and Devices Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Contraceptive Drugs and Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Global Contraceptive Drugs and Devices Market - Industry Life Cycle |
3.4 Global Contraceptive Drugs and Devices Market - Porter's Five Forces |
3.5 Global Contraceptive Drugs and Devices Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Contraceptive Drugs and Devices Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.7 Global Contraceptive Drugs and Devices Market Revenues & Volume Share, By Gender, 2021 & 2031F |
4 Global Contraceptive Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Contraceptive Drugs and Devices Market Trends |
6 Global Contraceptive Drugs and Devices Market, 2021 - 2031 |
6.1 Global Contraceptive Drugs and Devices Market, Revenues & Volume, By Products, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Contraceptive Drugs and Devices Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.1.3 Global Contraceptive Drugs and Devices Market, Revenues & Volume, By Devices, 2021 - 2031 |
6.2 Global Contraceptive Drugs and Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Contraceptive Drugs and Devices Market, Revenues & Volume, By Male, 2021 - 2031 |
6.2.3 Global Contraceptive Drugs and Devices Market, Revenues & Volume, By Female, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Contraceptive Drugs and Devices Market, Overview & Analysis |
7.1 North America Contraceptive Drugs and Devices Market Revenues & Volume, 2021 - 2031 |
7.2 North America Contraceptive Drugs and Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Contraceptive Drugs and Devices Market, Revenues & Volume, By Products, 2021 - 2031 |
7.4 North America Contraceptive Drugs and Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
8 Latin America (LATAM) Contraceptive Drugs and Devices Market, Overview & Analysis |
8.1 Latin America (LATAM) Contraceptive Drugs and Devices Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Contraceptive Drugs and Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Contraceptive Drugs and Devices Market, Revenues & Volume, By Products, 2021 - 2031 |
8.4 Latin America (LATAM) Contraceptive Drugs and Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
9 Asia Contraceptive Drugs and Devices Market, Overview & Analysis |
9.1 Asia Contraceptive Drugs and Devices Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Contraceptive Drugs and Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Contraceptive Drugs and Devices Market, Revenues & Volume, By Products, 2021 - 2031 |
9.4 Asia Contraceptive Drugs and Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
10 Africa Contraceptive Drugs and Devices Market, Overview & Analysis |
10.1 Africa Contraceptive Drugs and Devices Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Contraceptive Drugs and Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Contraceptive Drugs and Devices Market, Revenues & Volume, By Products, 2021 - 2031 |
10.4 Africa Contraceptive Drugs and Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
11 Europe Contraceptive Drugs and Devices Market, Overview & Analysis |
11.1 Europe Contraceptive Drugs and Devices Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Contraceptive Drugs and Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Contraceptive Drugs and Devices Market, Revenues & Volume, By Products, 2021 - 2031 |
11.4 Europe Contraceptive Drugs and Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
12 Middle East Contraceptive Drugs and Devices Market, Overview & Analysis |
12.1 Middle East Contraceptive Drugs and Devices Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Contraceptive Drugs and Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Contraceptive Drugs and Devices Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Contraceptive Drugs and Devices Market, Revenues & Volume, By Products, 2021 - 2031 |
12.4 Middle East Contraceptive Drugs and Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
13 Global Contraceptive Drugs and Devices Market Key Performance Indicators |
14 Global Contraceptive Drugs and Devices Market - Export/Import By Countries Assessment |
15 Global Contraceptive Drugs and Devices Market - Opportunity Assessment |
15.1 Global Contraceptive Drugs and Devices Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Contraceptive Drugs and Devices Market Opportunity Assessment, By Products, 2021 & 2031F |
15.3 Global Contraceptive Drugs and Devices Market Opportunity Assessment, By Gender, 2021 & 2031F |
16 Global Contraceptive Drugs and Devices Market - Competitive Landscape |
16.1 Global Contraceptive Drugs and Devices Market Revenue Share, By Companies, 2024 |
16.2 Global Contraceptive Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |